Effect of Combined Hormonal and Insulin Therapy on the Steroid Hormone Receptors and Growth Factors Signalling in Diabetic Mice Prostate

Overview

Journal Int J Exp Pathol

Publisher Wiley

Specialty Pathology

Date 2010 Nov 3

PMID 21039986

Citations 5

Authors

Wagner J Favaro

Valeria H A Cagnon

Affiliations

Soon will be listed here.

Abstract

Diabetes causes harmful effects on prostatic morphology and function. However, there still are doubts about the occurrence of various diseases in the prostate, as well as abnormal angiogenesis in relation to diabetes. Thus, the aim of this study was to correlate and quantify the level of the steroid hormone receptors and the angiogenic and antiangiogenic factors in non-obese diabetic mice (Nod) after combined hormonal and insulin therapy. Sixty mice were divided into six groups after 20 days of diabetes: the control group received 0.9% NaCl, as did the diabetic group. The diabetic-insulin group received insulin, the diabetic-testosterone group received testosterone cypionate, the diabetic-oestrogen group received 17β-oestradiol, and the diabetic-insulin-testosterone-oestrogen group received insulin, testosterone and oestrogen simultaneously. After 20 days, the ventral lobe was processed for immunocytochemical and hormonal analyses. The results showed that the lowest serum testosterone and androgen receptor levels were found in the diabetic group and the highest testosterone and androgen receptor levels in the diabetic-insulin-testosterone-oestrogen group. The serum oestrogen level and its receptor showed changes opposite to those of testosterone and its receptor. The endostatin reactivity was mainly decreased in diabetic mice. The greatest IGFR-1 and VEGF reactivities occurred in diabetic mice. Thus, diabetes led to the prostatic hormonal imbalance, affecting molecular dynamics and angiogenesis in this organ. Combined insulin and steroid hormone therapy partially restored the hormonal and angiogenic imbalance caused by diabetes.

Citing Articles

Mechanistic insights into the use of rhubarb in diabetic kidney disease treatment using network pharmacology.

Gao Y, Nan Z Medicine (Baltimore). 2022; 101(1):e28465.

PMID: 35029893 PMC: 8735741. DOI: 10.1097/MD.0000000000028465.

Physical resistance training-induced changes in lipids metabolism pathways and apoptosis in prostate.

Teixeira G, Mendes L, Veras A, Thorpe H, Favaro W, de Almeida Chuffa L Lipids Health Dis. 2020; 19(1):14.

PMID: 31996229 PMC: 6990525. DOI: 10.1186/s12944-020-1195-0.

Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.

L-Lopez F, Sarmento-Cabral A, Herrero-Aguayo V, Gahete M, Castano J, Luque R J Cell Mol Med. 2017; 21(9):1893-1904.

PMID: 28244645 PMC: 5571563. DOI: 10.1111/jcmm.13109.

Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.

Gobbo M, Dizeyi N, Abrahamsson P, Bertilsson P, Masiteli V, Pytlowanciv E J Diabetes Res. 2015; 2015:538529.

PMID: 26295055 PMC: 4534615. DOI: 10.1155/2015/538529.

Chronic rapamycin treatment causes diabetes in male mice.

Schindler C, Partap U, Patchen B, Swoap S Am J Physiol Regul Integr Comp Physiol. 2014; 307(4):R434-43.

PMID: 24965794 PMC: 4137151. DOI: 10.1152/ajpregu.00123.2014.

References

McPherson S, Ellem S, Simpson E, Patchev V, Fritzemeier K, Risbridger G . Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology. 2006; 148(2):566-74. DOI: 10.1210/en.2006-0906. View

Risbridger G, Wang H, Young P, Kurita T, Wang Y, Lubahn D . Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol. 2001; 229(2):432-42. DOI: 10.1006/dbio.2000.9994. View

Chan Q, Lam H, Ng C, Lee A, Chan E, Ng H . Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ. 2010; 17(9):1511-23. PMC: 2897932. DOI: 10.1038/cdd.2010.20. View

Shirai H, Sato T, Hara T, Minagi S . The effect of diabetes mellitus on histopathological changes in the tissues under denture base and without mechanical pressure. J Oral Rehabil. 1998; 25(9):715-20. DOI: 10.1046/j.1365-2842.1998.00301.x. View

Franck-Lissbrant I, Haggstrom S, Damber J, Bergh A . Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology. 1998; 139(2):451-6. DOI: 10.1210/endo.139.2.5683. View

Lazari M, Gameiro Lucas T, Yasuhara F, Gomes G, Siu E, Royer C . Estrogen receptors and function in the male reproductive system. Arq Bras Endocrinol Metabol. 2010; 53(8):923-33. DOI: 10.1590/s0004-27302009000800005. View

Zhang Z, Duan L, Du X, Ma H, Park I, Lee C . The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate. 2008; 68(5):508-16. DOI: 10.1002/pros.20722. View

Prins G, Birch L, Couse J, Choi I, Katzenellenbogen B, Korach K . Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 2001; 61(16):6089-97. View

Nishi N, Oya H, Matsumoto K, Nakamura T, Miyanaka H, Wada F . Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates. Prostate. 1996; 28(3):139-52. DOI: 10.1002/(SICI)1097-0045(199603)28:3<139::AID-PROS1>3.0.CO;2-A. View

10.

Ballester J, Munoz M, Dominguez J, Rigau T, Guinovart J, Rodriguez-Gil J . Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. J Androl. 2004; 25(5):706-19. DOI: 10.1002/j.1939-4640.2004.tb02845.x. View

11.

Tesone M, de Souza Valle L, FOGLIA V, Charreau E . Endocrine function of the testis in streptozotocin diabetic rats. Acta Physiol Lat Am. 1976; 26(5):387-94. View

12.

Risbridger G, BIANCO J, Ellem S, McPherson S . Oestrogens and prostate cancer. Endocr Relat Cancer. 2003; 10(2):187-91. DOI: 10.1677/erc.0.0100187. View

13.

Kasper J, Liu Y, Pollak M, Rifai N, Giovannucci E . Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control. 2008; 19(7):703-10. DOI: 10.1007/s10552-008-9133-x. View

14.

Ikeda K, Wada Y, Foster Jr H, Wang Z, Weiss R, Latifpour J . Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta. J Urol. 2000; 164(1):180-5. View

15.

Gnanapragasam V, Robson C, Leung H, Neal D . Androgen receptor signalling in the prostate. BJU Int. 2000; 86(9):1001-13. DOI: 10.1046/j.1464-410x.2000.00943.x. View

16.

Naslund M, Strandberg J, Coffey D . The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol. 1988; 140(5):1049-53. DOI: 10.1016/s0022-5347(17)41924-0. View

17.

Beeson P . Age and sex associations of 40 autoimmune diseases. Am J Med. 1994; 96(5):457-62. DOI: 10.1016/0002-9343(94)90173-2. View

18.

Ohta T, Matsui K, Miyajima K, Sasase T, Masuyama T, Shoda T . Effect of insulin therapy on renal changes in spontaneously diabetic Torii rats. Exp Anim. 2007; 56(5):355-62. DOI: 10.1538/expanim.56.355. View

19.

OReilly M, Boehm T, Shing Y, Fukai N, Vasios G, Lane W . Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997; 88(2):277-85. DOI: 10.1016/s0092-8674(00)81848-6. View

20.

Daubresse J, Meunier J, Wilmotte J, Luyckx A, Lefebvre P . Pituitary-testicular axis in diabetic men with and without sexual impotence. Diabete Metab. 1978; 4(4):233-7. View